Theodore Karrison to Early Termination of Clinical Trials
This is a "connection" page, showing publications Theodore Karrison has written about Early Termination of Clinical Trials.
Connection Strength
0.026
-
A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study. Prostate Cancer Prostatic Dis. 2012 Mar; 15(1):87-92.
Score: 0.026